Eli Lilly’s Donanemab: Independent Panel Recommends FDA Approval for Early-Stage Alzheimer’s Treatment Summary: An independent advisory panel has recommended that the U.S. Food and Drug Administration (FDA) approve Eli Lilly’s monoclonal antibody therapy Donanemab for the treatment of early-stage Alzheimer’s disease. The recommendation follows clinical trial data showing the drug slows disease progression, though notable … Read more

How do we motivate ourselves and others to act? The answer lies largely in motivation. People respond to both external incentives—money, status, promotion, or social approval—and internal drivers such as beliefs, values, and personal goals. While external rewards can prompt action, intrinsic motivation is usually more powerful and more sustainable over time. Feeling autonomous—like the … Read more

New research indicates that older women who report memory problems are more likely to receive a diagnosis of memory or thinking impairment years later. The study was published online October 28, 2015, in the journal Neurology. “Subjective memory complaints can be an early sign of a slowly progressing process such as Alzheimer’s disease,” said Allison … Read more

Anxiety is a normal part of life and something most of us experience from time to time. When worry, nervousness, or fear begin to dominate your days, it can feel overwhelming. Many people develop effective strategies to cope with occasional anxiety, but when anxiety starts interfering with daily life, seeking professional support is an important … Read more

Summary: A new Columbia University analysis shows depression burden in the United States is highest among women, adolescents and young adults, while treatment levels remain low. Source: Columbia University A recent study by researchers at Columbia University Mailman School of Public Health and the City University of New York reports widespread increases in depression across … Read more

Summary: New research from the University of Eastern Finland indicates that a prior traumatic brain injury (TBI) raises the likelihood of developing frontotemporal dementia (FTD) among people without a known genetic cause. The studies also find that, on average, people with FTD have lower educational attainment than those with Alzheimer’s disease, and that some cardiovascular … Read more

A company’s success depends on effective individuals and well-integrated teams. Collaborating productively, maintaining high performance, and supporting employee wellbeing are essential for sustained business results. Interpersonal dynamics are shaped largely by personality rather than only by technical skills or expertise. Consequently, many organizations use personality profiling to assemble balanced, high-performing teams. This article reviews one … Read more

Glymphatic System: How the Brain Clears Waste and Why It Matters for Alzheimer’s Researchers at the University of Rochester Medical Center describe a recently characterized brain waste-clearance pathway—the glymphatic system—as a promising target for treating neurological disorders such as Alzheimer’s disease. They suggest that impaired clearance of cellular waste may contribute to the development of … Read more

Tanning Activates Addictive Pathways in the Brain Researchers at the University of Colorado Anschutz Medical Campus have identified a clear association between indoor tanning and substance use among Colorado high school students. Their analysis, published in JAMA Dermatology, suggests that motivations for indoor tanning and overlapping biological mechanisms may help explain why tanning is linked … Read more

You’re unlikely to meet anyone who enjoys interviews. No matter your experience, interviews often trigger anxiety—usually not because of the interview itself but because of unexpected, personal questions. Beyond basic skills and experience, interviewers may ask questions such as “How good are you at asking for help?” or “How do you create balance in your … Read more